US Food and Drug Administration Support for Oncology Drug Development During COVID-19

被引：4
|
作者：
Kadakia, Kushal T. [1 ]
Pazdur, Richard [1 ]
Shah, Anand [1 ]
机构：
[1] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 01期
关键词：
D O I：
10.1001/jamaoncol.2020.4975
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This Viewpoint seeks to contextualize recent US Food and Drug Administration guidance on clinical trials during COVID-19 to oncology and to share insight regarding regulatory challenges and lessons learned.
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [1] Oncology Drug Development and Approval of Systemic Anticancer Therapy by the US Food and Drug Administration
    Martell, Robert E.
    Sermer, David
    Getz, Kenneth
    Kaitin, Kenneth I.
    ONCOLOGIST, 2013, 18 (01): : 104 - 111
  • [2] The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
    Ida-Lina Diak
    Kimberley Swank
    Kate McCartan
    Maya Beganovic
    James Kidd
    Neha Gada
    Rachna Kapoor
    Lisa Wolf
    Laura Kangas
    Jo Wyeth
    Toni Salvatore
    Melina Fanari
    Andrew A. LeBoeuf
    Poonam Mishra
    Michael D. Blum
    Gerald Dal Pan
    Drug Safety, 2023, 46 : 145 - 155
  • [3] The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic
    Diak, Ida-Lina
    Swank, Kimberley
    McCartan, Kate
    Beganovic, Maya
    Kidd, James
    Gada, Neha
    Kapoor, Rachna
    Wolf, Lisa
    Kangas, Laura
    Wyeth, Jo
    Salvatore, Toni
    Fanari, Melina
    LeBoeuf, Andrew A.
    Mishra, Poonam
    Blum, Michael D.
    Dal Pan, Gerald
    DRUG SAFETY, 2023, 46 (02) : 145 - 155
  • [4] Oncology drug development: United States Food and Drug Administration perspective
    Hirschfeld, S
    Pazdur, R
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 42 (02) : 137 - 143
  • [5] COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine
    Scherer, Aaron M.
    Parker, Andrew M.
    Gidengil, Courtney A.
    Gedlinske, Amber M.
    Askelson, Natoshia M.
    Petersen, Christine A.
    Lindley, Megan C.
    JAMA INTERNAL MEDICINE, 2022, 182 (06) : 678 - 680
  • [6] COVID-19 Drug Development
    Kim, Seungtaek
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 32 (01) : 1 - 5
  • [7] Immuno-oncology drug development forges on despite COVID-19
    Upadhaya, Samik
    Hubbard-Lucey, Vanessa M.
    Yu, Jia Xin
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) : 751 - 752
  • [8] Comparison of Oncology Drug Approval Between Health Canada and the US Food and Drug Administration
    Ezeife, Doreen A.
    Truong, Tony H.
    Heng, Daniel Y. C.
    Bourque, Sylvie
    Welch, Stephen A.
    Tang, Patricia A.
    CANCER, 2015, 121 (10) : 1688 - 1693
  • [9] Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's Actions
    Haslam, Alyson
    Gill, Jennifer
    Prasad, Vinay
    MAYO CLINIC PROCEEDINGS, 2020, 95 (02) : 424 - 426
  • [10] Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada
    Lythgoe, Mark P.
    Middleton, Paul
    JAMA NETWORK OPEN, 2021, 4 (06)
12345